NDC 12634-729

Glipizide

Glipizide

Glipizide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Glipizide.

Product ID12634-729_463a6f4a-c834-2e89-e054-00144ff8d46c
NDC12634-729
Product TypeHuman Prescription Drug
Proprietary NameGlipizide
Generic NameGlipizide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-07-18
Marketing CategoryANDA / ANDA
Application NumberANDA074550
Labeler NameApotheca Inc.
Substance NameGLIPIZIDE
Active Ingredient Strength5 mg/1
Pharm ClassesSulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 12634-729-00

10 TABLET in 1 BOTTLE (12634-729-00)
Marketing Start Date2011-07-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 12634-729-59 [12634072959]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-09 [12634072909]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-96 [12634072996]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-42 [12634072942]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-69 [12634072969]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-84 [12634072984]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-78 [12634072978]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-94 [12634072994]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-99 [12634072999]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-54 [12634072954]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-80 [12634072980]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-90 [12634072990]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-01 [12634072901]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-95 [12634072995]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-79 [12634072979]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-93 [12634072993]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-12 [12634072912]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-85 [12634072985]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-40 [12634072940]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-74 [12634072974]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-57 [12634072957]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-63 [12634072963]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-66 [12634072966]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-52 [12634072952]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-18 [12634072918]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-67 [12634072967]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-71 [12634072971]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-98 [12634072998]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-50 [12634072950]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-00 [12634072900]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-82 [12634072982]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-97 [12634072997]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-45 [12634072945]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-81 [12634072981]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-92 [12634072992]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-61 [12634072961]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-60 [12634072960]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-729-91 [12634072991]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

Drug Details

Active Ingredients

IngredientStrength
GLIPIZIDE5 mg/1

OpenFDA Data

SPL SET ID:463a6f4a-c833-2e89-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310490

    • Pharmacological Class

    • Sulfonylurea [EPC]
    • Sulfonylurea Compounds [CS]
    • Sulfonylurea [EPC]
    • Sulfonylurea Compounds [CS]

    NDC Crossover Matching brand name "Glipizide" or generic name "Glipizide"

    NDCBrand NameGeneric Name
    0378-1105Glipizideglipizide
    0378-1110Glipizideglipizide
    0591-0460GlipizideGlipizide
    0591-0461GlipizideGlipizide
    0591-0844GlipizideGlipizide
    0591-0845GlipizideGlipizide
    0591-0900GlipizideGlipizide
    0615-3595GlipizideGlipizide
    0615-3596GlipizideGlipizide
    0615-5584GlipizideGlipizide
    0615-5585GlipizideGlipizide
    0615-6596GlipizideGlipizide
    0615-7968GlipizideGlipizide
    0615-7969GlipizideGlipizide
    0615-8407GlipizideGlipizide
    68071-1773GlipizideGlipizide
    68071-3009GlipizideGlipizide
    68071-3141GlipizideGlipizide
    68071-4223GlipizideGlipizide
    68071-4124GlipizideGlipizide
    68071-4085GlipizideGlipizide
    68071-4378GlipizideGlipizide
    68071-4498GlipizideGlipizide
    68071-4020GlipizideGlipizide
    68071-4232GlipizideGlipizide
    68071-4643GlipizideGlipizide
    68382-337GlipizideGlipizide
    68382-336GlipizideGlipizide
    68382-335GlipizideGlipizide
    68645-575GlipizideGlipizide
    68788-0141GlipizideGlipizide
    68645-151GlipizideGlipizide
    68645-574GlipizideGlipizide
    68788-0142GlipizideGlipizide
    68788-7250GlipizideGlipizide
    68788-6853GlipizideGlipizide
    68788-6854GlipizideGlipizide
    68788-9176GlipizideGlipizide
    68788-7230GlipizideGlipizide
    68788-9918GlipizideGlipizide
    70518-0029GlipizideGlipizide
    70518-0104GlipizideGlipizide
    70518-0552GlipizideGlipizide
    70518-0115GlipizideGlipizide
    70518-0389GlipizideGlipizide
    70518-0358GlipizideGlipizide
    70518-1124GlipizideGlipizide
    70518-0998GlipizideGlipizide
    70518-1063GlipizideGlipizide
    70518-0574GlipizideGlipizide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.